Tesamorelin
GHRH analog targeting visceral fat reduction
Enter your location to see the estimated shipping cost before checkout.
• Major cities (JHB, CPT, DBN): R195 overnight
• Outlying areas: R275 (2-3 business days)
• Collect in person: Free (Sandton location)
Tesamorelin is a synthetic peptide analog of the human growth hormone-releasing hormone (GHRH). It is specifically engineered for research applications focusing on metabolic disorders and body composition changes. This compound is primarily utilized to investigate the reduction of visceral adipose tissue (VAT).
- •Potent agonist of the GHRH receptor.
- •Tool for studying lipodystrophy mechanisms.
- •Enables research into VAT reduction strategies.
- •Valuable compound for metabolic syndrome models.
- •Facilitates studies on abdominal fat accumulation.
- •Supports investigations into endogenous GH pulsatility.
Tesamorelin functions as a GHRH agonist, binding specifically to the growth hormone-releasing hormone receptor (GHRHR) located on somatotroph cells within the anterior pituitary gland. This binding activates the GHRHR, initiating a signaling cascade, primarily via the cAMP/PKA pathway, which stimulates the synthesis and pulsatile release of endogenous growth hormone (GH). Unlike direct GH administration, Tesamorelin preserves the physiological pulsatile pattern of GH secretion. The resulting increase in circulating GH subsequently acts on target tissues, stimulating the production of insulin-like growth factor-1 (IGF-1) in the liver. The combined action of GH and IGF-1 is hypothesized to promote lipolysis and inhibit lipogenesis specifically within the visceral fat compartment, leading to a reduction in VAT without significantly affecting subcutaneous fat.
The primary research application for Tesamorelin involves the study of pathological fat redistribution, particularly in models of HIV-associated lipodystrophy. Its targeted action on VAT makes it an essential tool for understanding the mechanisms underlying central obesity and its associated metabolic complications. Further scientific applications include investigating the hypothalamic-pituitary-somatic axis regulation and exploring therapeutic strategies for metabolic syndrome. Researchers utilize Tesamorelin to elucidate the complex interplay between GH, IGF-1, and lipid metabolism, providing insights into potential pharmacological interventions for improving body composition and reducing cardiovascular risk factors associated with excessive visceral adiposity.
Based on research applications and synergistic mechanisms, this peptide is frequently combined with:
No reviews yet. Be the first to review Tesamorelin!
Have a question about Tesamorelin? Ask here and get answers from our team or other researchers.
No questions yet. Be the first to ask about Tesamorelin!
MOTS-C
Mitochondrial-derived peptide for metabolic health
AOD 9604
Modified HGH fragment for fat loss
HGH Fragment 176-191
Synthetic HGH fragment for fat loss
AICAR
Exercise mimetic and metabolic enhancer
Customers who viewed Tesamorelin also looked at these products
Research Use Only
This product is sold strictly for research purposes only. It is not approved by the FDA for human consumption or medical use. Intended for laboratory and research applications by qualified researchers and institutions only.